Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Risk Factors in Patients Who Had Prior Renal or Liver Transplant Undergoing Primary Total Hip Arthroplasty
Gill, Vikram S., Mansour, Elie , Jawdeh, Bassam G. Abu , Khan, Muhammad Ali , McGary, Alyssa , Spangehl, Mark J. , Ledford, Cameron K. , Bingham, Joshua S. , Boddu, Sayi P. , Mansour, Elie , Abu Jawdeh, Bassam G , Khan, Muhammad Ali , Clarke, Henry, Spangehl, Mark , Ledford, Cameron K , Bingham, Joshua S , Clarke, Henry D. , Abdel, Matthew P.

Journal of Clinical Medicine | May 16, 2025 | Volume: 14 | Issue: 10 | Pages: 3486

10.3390/jcm14103486 | PMID 40429481 Get It

Background: Solid organ transplant (SOT) recipients are living longer and, consequently, more of them require elective total hip arthroplasty (THA) to restore mobility and improve quality of life. Because these patients are chronically immunosuppressed and often burdened by multiple comorbidities, their peri-operative risk profile may differ substantially from that of the general THA population. This study aimed to evaluate risk factors associated with acute medical and surgical complications, implant survivorship, and overall mortality in patients with a history of SOT who underwent THA. Methods: A total of 173 THA procedures were reviewed in patients with previous SOT. Among them, 64 had undergone liver transplantation (LT), 83 had received renal transplants (RT), and 26 had experienced more than one type of organ transplant (MT). Kaplan–Meier survival analysis was employed to estimate median survival. Complications were examined using univariate analysis through mixed-effects logistic regression, while Cox regression was utilized to assess mortality risk. The median follow-up period extended to 99 months. Results: The proportion of patients experiencing at least one acute medical event was 27% in the LT group, 33% in the RT group, and 38% in the MT group, with no statistically significant difference between groups (p = 0.5). American Society of Anesthesiologists Class (ASA) 4 (Odds Ratio (OR) = 28; p = 0.006) and treatment with bisphosphonates (OR = 2.25; p = 0.03) were associated with higher risk of acute medical complications. Increased age at the time of SOT was linked to a reduced likelihood of surgical complications (OR = 0.94, p = 0.008), as was older age at the time of undergoing THA (OR = 0.92, p = 0.001). The observed rates of reoperation and implant revision were 3% and 1%, respectively. The estimated patient survivorship rates at 1, 5, and 10 years were 98.6, 82, and 58.4%, respectively. Older age at SOT (Hazard Ratio (HR) = 1.06, p < 0.001), at THA (HR = 1.08, p < 0.001), ASA 4 at THA (HR = 7.57, p = 0.02), and atrial fibrillation (AFib) (HR = 3.13, p = 0.02) were associated with higher mortality. Conclusions: ASA 4 and bisphosphonates were associated with a higher risk of acute medical complications, whereas older age was associated with lower surgical complications. Additionally, older age, ASA 4, and AFib were associated with higher mortality.
Facial Analysis for Plastic Surgery in the Era of Artificial Intelligence: A Comparative Evaluation of Multimodal Large Language Models
Haider, Syed Ali , Genovese, Ariana , Trabilsy, Maissa , Yang, Jenny Fei, Galvao, Andrea , Tao, Cui , Forte, Antonio J. , Elegbede, Adekunle, Galvao, Andrea , Tao, Cui , Forte, Antonio Jorge , Haider, Syed A , Genovese, Ariana , Prabha, Srinivasagam , Gomez-Cabello, Cesar A. , Borna, Sahar , Elegbede, Adekunle I. , Yang, Jenny Fei

Journal of Clinical Medicine | May 16, 2025 | Volume: 14 | Issue: 10 | Pages: 3484

10.3390/jcm14103484 | PMID 40429479 Get It

Background/Objectives: Facial analysis is critical for preoperative planning in facial plastic surgery, but traditional methods can be time consuming and subjective. This study investigated the potential of Artificial Intelligence (AI) for objective and efficient facial analysis in plastic surgery, with a specific focus on Multimodal Large Language Models (MLLMs). We evaluated their ability to analyze facial skin quality, volume, symmetry, and adherence to aesthetic standards such as neoclassical facial canons and the golden ratio. Methods: We evaluated four MLLMs—ChatGPT-4o, ChatGPT-4, Gemini 1.5 Pro, and Claude 3.5 Sonnet—using two evaluation forms and 15 diverse facial images generated by a Generative Adversarial Network (GAN). The general analysis form evaluated qualitative skin features (texture, type, thickness, wrinkling, photoaging, and overall symmetry). The facial ratios form assessed quantitative structural proportions, including division into equal fifths, adherence to the rule of thirds, and compatibility with the golden ratio. MLLM assessments were compared with evaluations from a plastic surgeon and manual measurements of facial ratios. Results: The MLLMs showed promise in analyzing qualitative features, but they struggled with precise quantitative measurements of facial ratios. Mean accuracy for general analysis were ChatGPT-4o (0.61 ± 0.49), Gemini 1.5 Pro (0.60 ± 0.49), ChatGPT-4 (0.57 ± 0.50), and Claude 3.5 Sonnet (0.52 ± 0.50). In facial ratio assessments, scores were lower, with Gemini 1.5 Pro achieving the highest mean accuracy (0.39 ± 0.49). Inter-rater reliability, based on Cohen’s Kappa values, ranged from poor to high for qualitative assessments (κ > 0.7 for some questions) but was generally poor (near or below zero) for quantitative assessments. Conclusions: Current general purpose MLLMs are not yet ready to replace manual clinical assessments but may assist in general facial feature analysis. These findings are based on testing models not specifically trained for facial analysis and serve to raise awareness among clinicians regarding the current capabilities and inherent limitations of readily available MLLMs in this specialized domain. This limitation may stem from challenges with spatial reasoning and fine-grained detail extraction, which are inherent limitations of current MLLMs. Future research should focus on enhancing the numerical accuracy and reliability of MLLMs for broader application in plastic surgery, potentially through improved training methods and integration with other AI technologies such as specialized computer vision algorithms for precise landmark detection and measurement.
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis
Couteur, David G. Le , Wilanksy, Susan, Lester, Steven J., Ommen, Steve R. , Geske, Jeffrey B. , Arsanjani, Reza, Ayoub, Chadi , Pereyra Pietri, Milagros, Pathangey, Girish , Le Couteur, David , Geske, Jeffrey B , Ayoub, Chadi , Awad, Kamal , Pereyra, Milagros , Farina, Juan M. , Abbas, Mohammed Tiseer , Scalia, Isabel G. , Arsanjani, Reza

European Heart Journal - Cardiovascular Pharmacotherapy | May 16, 2025 | Volume: 11 | Issue: 5 | Pages: 469-482

10.1093/ehjcvp/pvaf036 | PMID 40377024 Get It

Abstract Aims Significant advancements have been made in the management of obstructive hypertrophic cardiomyopathy (oHCM), yet the extent of left ventricular outflow tract (LVOT) gradient reduction achieved with commonly used pharmacological therapies [beta-blockers (BBs), calcium channel blockers (CCBs), disopyramide, and cardiac myosin inhibitors (CMIs)] relative to each other is still unclear. Methods and results PubMed and Scopus were searched up to September 2024. Clinical trials or observational studies that assessed the changes associated with BBs, CCBs, disopyramide, or CMIs in LVOT gradient at rest or with provocation in patients with oHCM were included. Mean changes in LVOT gradients were pooled as mean differences (MD) with 95% confidence intervals (CIs) in a random-effects model. Thirty-seven studies, with 44 arms and 1898 patients, were included in the analysis. At the therapeutic class level, pooled analysis showed that disopyramide was associated with the highest reduction in LVOT gradient at rest [MD: −43.5 (95% CI, −51.6 to −35.3)], followed by CMIs [MD: −34.8 (95% CI, −40.6 to −29.0)], BBs [MD: −20.7 (95% CI, −29.4 to −12.0)], and then CCBs [MD: −14.7 (95% CI, −23.3 to −6.1)], inter-action P &lt; 0.01. Within CMIs, mavacamten had a higher effect than aficamten on gradient reduction; among the included BBs, metoprolol showed the highest gradient reduction, while among CCBs, verapamil was the most effective (inter-action P &lt; 0.01). Similar results were observed for provocable LVOT gradients. Conclusion Pharmacological therapies effectively reduced LVOT gradients in oHCM patients to varying degrees, with disopyramide and CMIs showing the highest effect, followed by BBs and CCBs.
In Vitro Activity of Nisin A Against Staphylococci Isolated from Periprosthetic Joint Infection
Karau, Melissa J. , Koscianski, Christina, Badley, Andrew D. , Bedard, Nicholas A. , Zinckgraf, John W. , Patel, Robin , Koscianski, Christina A , Patel, Robin , Badley, Andrew D , Bedard, Nicholas A

Antibiotics | May 16, 2025 | Volume: 14 | Issue: 5 | Pages: 515

10.3390/antibiotics14050515 | PMID 40426581 Get It

Background/Objectives: Staphylococci are the most common causes of periprosthetic joint infection (PJI); new antimicrobials are needed to manage these difficult infections. Nisin A is a lantibiotic peptide derived from Lactococcus lactis that has antimicrobial activity against Gram-positive bacteria, including staphylococci, and is an FDA-approved preservative used in the food and dairy industry. Here, the in vitro nisin A susceptibility of PJI-associated staphylococci was assessed. Methods: The minimum inhibitory concentrations (MICs), minimum biofilm inhibitory concentrations (MBICs), and minimum biofilm bactericidal concentrations (MBBCs) of nisin A were measured by broth microdilution against 106 staphylococcus isolates isolated from PJI. MICs were assessed using 5 × 105 CFU/mL plus nisin A. For MBICs, biofilms were grown on pegged lids for 6 h, followed by 20 h of treatment. For MBBCs, pegged lids were transferred to plates containing media only for 20 h. The results were determined as the lowest concentrations with no visual growth. Two-dimensional MICs with nisin A and vancomycin were assessed for 20 isolates. Fractional inhibitory concentrations (FICs) were calculated to determine synergistic, additive, antagonistic, or indifferent interactions. Results: The MIC that inhibited 90% of S. aureus and S. epidermidis was 4 µg/mL, apart from for the MRSA subset (8 µg/mL). The MBIC that inhibited 90% of isolates was 4 µg/mL. The MBBCs ranged from 4 to 256 µg/mL. When tested together, nisin A and vancomycin yielded an FIC between 1.25 and 1.5, indicative of indifference, except for one isolate each of MRSA and MSSA, for which an additive effect (FIC of 1) was observed. Conclusions: Nisin A showed inhibitory activity against staphylococci that cause PJI.
Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort
Vaca‐Cartagena, Bryan F. , Mesa-Chávez, Fernanda , Azim, Hatem A. , Platas, Alejandra , Fonseca, Alan , Cruz‐Ramos, Marlid , Rodríguez, Ana María , Mohar, Alejandro , Guajardo, Ana S Ferrigno , Villarreal-Garza, Cynthia , Rotolo, Federico , Rodriguez, Ana, Villarreal‐Garza, Cynthia

Therapeutic Advances in Medical Oncology | May 16, 2025 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/17588359251337493 | PMID 40386468 Get It

Background: Young women with breast cancer (YWBC) typically undergo intensive treatment that negatively impacts their quality of life (QoL). However, limited information is available on how their QoL changes, as most research has focused on older patients. Objectives: To assess changes in QoL among YWBC, identify the most affected QoL domains, and identify the factors associated with these changes. Design: Joven & Fuerte is a multicenter cohort of women aged ⩽40 in Mexico with newly diagnosed BC from 2014 to 2020. Methods: Participants completed the European Organization for Research and Treatment of Cancer Breast Cancer module QLQ-BR23 questionnaire at five different time points from enrollment until year 5 postdiagnosis. Clinical and treatment data were also collected. Group-based multivariate trajectory modeling was used to analyze longitudinal changes across QoL domains and classify patients into appropriate groups. Logistic models were then employed to identify associations between variables and group classification. Results: A total of 477 women (median age: 36 years; interquartile range 32–38) were included. Most had public health insurance (87%) and were diagnosed with stage II (49%) or III (39%) BC. Two trajectory groups, namely, “good” and “poor,” were identified based on QLQ-BR23 scores. Most patients ( n = 294, 62%) were in the poor group. In the good group, sexual enjoyment scores remained stable from baseline to year 5 (51.4), whereas those in the poor group decreased (51.0–37.3). Distress related to hair loss over time declined, with scores decreasing from 36.3 to 27.0 in the good trajectory group and from 43.4 to 31.2 in the poor trajectory group. For future perspective, the good group improved from 56.4 to 79.0, while the poor group increased from 39.3 to 57.2. Patients with human epidermal growth factor receptor 2-positive BC (adjusted odds ratio (aOR) = 0.57, 95% confidence interval (CI) 0.35–0.94, p = 0.028) and those with public health insurance (aOR = 0.41, 95% CI 0.16–0.90, p = 0.035) were less likely to belong to the poor trajectory group. Conclusion: A high proportion of YWBC experience a poor QoL trajectory over time, particularly in areas related to sexual health, future perspective, and hair loss.
Modifiable Risk Factors in Transplant: Lifestyle Advice and Adherence in a Prospective Cohort Study
Ehlers, Shawna L. , Hughes, Christine A. , Decker, Paul A. , Kirsch, Janae L. , Kacel, Elizabeth L. , Ansell, Stephen M., Ebbert, Jon O. , Gastineau, Dennis A., Patten, Christi A. , Cerhan, James R. , Brockman, Tabetha A. , Decker, Paul A. , Hogan, William J. , Dispenzieri, Angela , Ansell, Stephen M. , Gastineau, Dennis A.

American Journal of Health Behavior | May 16, 2025 | Volume: 49 | Issue: 2 | Pages: 66-77

10.5993/ajhb.49.2.7 Get It

Objectives: Modifiable lifestyle factors are associated with morbidity and mortality in hematopoietic stem cell transplant (HSCT) survivors. The aims of the study were to examine: (a) receipt of provider advice to change behaviors, (b) health behavior change, and (c) how modifiable lifestyle factors might cluster together. Methods: Patients within a large HSCT program completed a survey (N =870) of lifestyle factors at pre-HSCT evaluation. The survey assessed self-reported adherence to American Cancer Society and HSCT guidelines for cancer survivorship in the year prior to a pre-HSCT evaluation. Lifestyle factors of interest were physical activity, fruit and vegetable consumption, tobacco use, alcohol use, and height/weight to calculate Body Mass Index (BMI). Results: Among patients not meeting all five guidelines (98%), 31% received provider advice to change. Between 10% and 42% reported healthy behavior change since diagnosis. Physical activity, fruit and vegetable consumption, and BMI were the most commonly clustered lifestyle behaviors. Conclusions: A considerable proportion of patients did not meet national guidelines for lifestyle factors. Results highlight an immediate opportunity to improve health care delivery and transplant outcomes via pre-HSCT lifestyle screening and implementation of effective health behavior change interventions.
Hospital–Community Partnerships and 30-Day All-Cause Readmission Rates in High-Need and Low-Need Communities
Park, Sinyoung , Hamadi, Hanadi , Carrier, Allison , Xu, Jing , Spaulding, Aaron , Zhao, Mei , Hamadi, Hanadi Y , Spaulding, Aaron , Zhao, Mei

Hospital Topics | May 16, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-10

10.1080/00185868.2025.2504377 | PMID 40375388 Get It

Cerebrovascular Vasospasms, Cerebral Sinus Venous Thrombosis, and Rapid Empyema Reaccumulation in a Child with a Coinfection of Fusobacterium nucleatum and Prevotella loescheii
Geiser, Rachel , Zorio, Onilia, Appavu, Brian

Journal of Child Neurology | May 16, 2025 | Volume: 40 | Issue: 7 | Pages: 563-565

10.1177/08830738251339048 | PMID 40375808 Get It

Fusobacterium nucleatum and Prevotella loescheii are anaerobic gram-negative rods that exist in the oral cavity. To our knowledge, pediatric central nervous system complications with these pathogens have not been well described. An 11-year-old previously healthy vaccinated female child presented for 2 weeks of sinusitis that progressed to left arm and leg hemiplegia. Initial neuroimaging demonstrated a superior sagittal sinus thrombosis and a right hemispheric subdural empyema with midline shift, necessitating surgical evacuation. Culture of the subdural accumulation demonstrated coinfection of Fusobacterium nucleatum and Prevotella loescheii . Within 24 hours of evacuation, the patient progressed to have right hemispheric electrographic status epilepticus, with neuroimaging demonstrating reaccumulation of the empyema and a moderate right middle cerebral artery vasospasm. Transcranial doppler ultrasonography of the right middle cerebral artery territory demonstrated mean flow velocities up to 148 cm/s with a Lindengaard ratio of 3.44. The patient underwent repeat subdural evacuation and was managed with intravenous fluids, permissive hypertension, oral nimodipine, and intravenous milrinone. Electrographic status epilepticus was treated with intravenous lacosamide and levetiracetam. Repeat neuroimaging demonstrated improvement in subdural collection size and resolution of vasospasms. She was discharged after 16 days with continued lacosamide and levetiracetam for seizures, and enoxaparin (Lovenox) for the superior sagittal sinus thrombosis. We present a novel pediatric case of Fusobacterium nucleatum and Prevotella loescheii manifesting with rapid subdural empyema reaccumulation after surgical evacuation, status epilepticus, cerebrovascular vasospasms, and cerebral sinus venous thrombosis. Further work is needed to understand the potential neurologic complications of this condition.
Role of Procalcitonin as a Prognostic Biomarker in Hospitalized COVID-19 Patients: A Comparative Analysis
Raavi, Lekhya , Jonna, Sadhana , NATARAJA, HRISHIKESH , Craver, Emily C. , Jenkins, Anna , Hanson, Abby , Balasubramanian, Prasanth , Tekin, Aysun, Bansal, Vikas , Reddy, Swetha , Caples, Sean M., Khan, Syed Anjum , Jain, Nitesh , LaNou, Abigail T. , Cartin‐Ceba, Rodrigo , Milian, Ricardo Diaz , Venegas, Carla , Shapiro, Anna B, Kiley, Sean , Quiñones, Quintin J., Patel, Neal M. , Roy, Archana , Sanghavi, Devang , Isha, Shahin , Hanson, Abby J, Balavenkataraman, Arvind , Bansal, Vikas , Jain, Nitesh K, Diaz Milian, Ricardo , Venegas, Carla P, Chaudhary, Sanjay , Kiley, Sean P, Roy, Archana , Sanghavi, Devang K., Jenkins, Anna, Tekin, Aysun , Kashyap, Rahul , Bhattacharyya, Anirban, Chaudhary, Sanjay , Guru, Pramod , Franco, Pablo Moreno

Biomarker Insights | May 16, 2025 | Volume: 20 | Issue: No issue available | Pages: No page available

10.1177/11772719241296624 | PMID 40386243 Get It

Background: Procalcitonin (PCT) is recognized as an inflammatory biomarker, often elevated in COVID-19 pneumonia alongside other biomarkers. Understanding its association with severe outcomes and comparing its predictive ability with other biomarkers is crucial for clinical management. Objectives: This retrospective multicenter observational study aimed to investigate the association between PCT levels and adverse outcomes in hospitalized COVID-19 patients. Additionally, it sought to compare the predictive performance of various biomarkers. Design: The study analyzed data from the Society of Critical Care Medicine (SCCM) Viral Infection and Respiratory Illness Universal Study (VIRUS) registry, comprising COVID-19 patients hospitalized across multiple Mayo Clinic sites between March 2020 and June 2022. Methods: A total of 7851 adult COVID-19 patients were included. Patients were categorized into 6 groups based on the worst WHO ordinal scale. Multivariate models were constructed using peak biomarker levels within 72 hours of admission, adjusted for confounders. Results: Elevated PCT levels were independently associated with increased odds of adverse outcomes, including ICU admission (adjusted odds ratio [aOR] 1.32, 95%CI 1.27-1.38), IMV requirement (aOR 1.35, 95%CI: 1.28-1.42), and in-hospital mortality (aOR 1.30, 95%CI: 1.22-1.37). A 3.48-fold increase in IMV requirement and 3.55 times increase in in-hospital mortality were noted with peak PCT ⩾ 0.25 ng/ml. Similar associations were observed with other biomarkers like NLR (AUC 0.730), CRP, IL-6, LDH (AUC 0.800), and D-dimer (AUC 0.719). Models incorporating NLR, LDH, D-dimer, and PCT demonstrated the highest predictive accuracy, with a combined model exhibiting an area under the curve (AUC) of 0.826 (95%CI 0.803-0.849). Conclusions: Higher PCT levels were significantly linked to worse outcomes in COVID-19 patients, emphasizing its potential as a prognostic marker. Biomarker-based predictive models, particularly those including PCT, showed promising utility for risk assessment and clinical decision-making. Further prospective studies are warranted to validate these findings on a larger scale.
Drug and Single-Cell Gene Expression Integration Identifies Sensitive and Resistant Glioblastoma Cell Populations
Suter, Robert K. , Jermakowicz, Anna M. , Veeramachaneni, Rithvik, D’Antuono, Matthew , Zhang, L.G., Chowdary, Rishika , Kaeppeli, Simon , Sharp, Madison, Palwai, Pravallika , Stathias, Vasileios , Baker, Grace, Ruiz, Luz , Walters, Winston, Cepero, Maria L., Reilly, Edward B. , Oleksijew, Anatol, Anderson, Mark G. , Williams, Siôn L. , Komotar, Ricardo J., Fuente, Macarena I. de la, Stein, Gregory , Wojcinski, Alexander, Schürer, Stephan C. , Ayad, Nagi , Zhang, Longwei , Burgenske, Danielle M , Williams, Sion Ll , Ivan, Michael E , Ayad, Nagi G , Palwai, Pravallika, Ruiz, Luz , Burgenske, Danielle M. , Williams, Sion Ll., Komotar, Ricardo J. , Wojcinski, Alexandre , Kesari, Santosh , Sarkaria, Jann N. , Ayad, Nagi G.

No container title available | May 15, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.15.654044 | PMID 40462892 Get It

Abstract Glioblastoma (GBM) remains the most common and lethal adult malignant primary brain cancer with few treatment options. A significant issue hindering GBM therapeutic development is intratumor heterogeneity. GBM tumors contain neoplastic cells within a spectrum of different transcriptional states. Identifying effective therapeutics requires a platform that predicts the differential sensitivity and resistance of these states to various treatments. Here, we developed a novel framework, ISOSCELES ( I nferred cell S ensitivity O perating on the integration of S ingle- C ell E xpression and L 1000 E xpression S ignatures), to quantify the cellular drug sensitivity and resistance landscape. Using single-cell RNA sequencing of newly diagnosed and recurrent GBM tumors, we identified compounds from the LINCS L1000 database with transcriptional response signatures selectively discordant with distinct GBM cell states. We validated the significance of these findings in vitro, ex vivo, and in vivo , and identified a novel combination of an OLIG2 inhibitor and Depatux-M for GBM. Our studies suggest that ISOSCELES identifies cell states sensitive and resistant to targeted therapies in GBM and that it can be applied to identify new synergistic combinations. Highlights Integration of GBM single-cell RNA sequencing data with L1000-derived drug response signatures facilitates clustering of tumor cells and small molecules on cell-drug connectivity. Cell-drug connectivity predicts the identities of drug-sensitive and resistant cell states. In silico perturbation analysis using cell-drug connectivity predicts drug-induced changes in the cell-drug connectivity landscape in vivo. In silico perturbation analysis to predict drug-induced changes in the tumor cell-drug connectivity landscape predicts drug combinations that synergize in vivo to extend survival.